Sadiq Azam | Clinical Microbiology | Best Researcher Award

Assoc. Prof. Dr. Sadiq Azam | Clinical Microbiology | Best Researcher Award

Associate Professor at University of Peshawsar, Pakistan

Dr. Sadiq Azam is an accomplished Associate Professor at the University of Peshawar, specializing in microbiology and biotechnology. With over a decade of academic and research experience, he has significantly contributed to understanding antibiotic resistance in pathogenic bacteria and the antimicrobial properties of medicinal plants. Dr. Azam began his academic career at Bacha Khan University and soon joined the University of Peshawar, where he has progressed through various academic ranks. His research includes several completed projects funded by the Higher Education Commission (HEC) and the Directorate of Science and Technology (DoST), focusing on bacteriological profiling, phytochemical analysis, and molecular characterization of drug-resistant pathogens. A certified supervisor, he has mentored numerous M.Phil, PhD, and undergraduate students. He is an active member of academic boards across various institutions and plays a vital role in curriculum development, examination coordination, and teaching innovation. Dr. Azam is fluent in English, Urdu, and Pashto.

Professional Profiles

Scopus

Education 

Dr. Sadiq Azam earned his PhD in Biotechnology from the University of Peshawar, where he had also completed his Bachelor’s in Biotechnology. Prior to his university education, he studied pre-medical sciences at Nisar Shaheed Degree College, Resalpur. His academic journey began with a foundation in science at Government High School, Swabi. Throughout his education, he focused on understanding biological systems and laboratory methodologies, which laid the groundwork for his later research in antimicrobial resistance, pathogenic microorganisms, and medicinal plant compounds. His doctoral work, supported by a prestigious HEC Indigenous Scholarship, marked the beginning of a research career centered on the intersection of microbiology, molecular biology, and pharmacognosy. The academic rigor and scientific training received throughout his education have shaped his multifaceted expertise in clinical microbiology and applied biotechnology. His educational foundation continues to support his teaching, research supervision, and grant-funded investigations in Pakistan’s higher education and health sectors.

Experience 

Dr. Azam’s professional journey began in 2011 as Assistant Professor at Bacha Khan University, Charsadda. He joined the University of Peshawar, where he advanced from Lecturer to Assistant Professor and now serves as an Associate Professor in the Centre for Biotechnology and Microbiology. With over 13 years of teaching and research experience, he has been involved in undergraduate and postgraduate education, thesis supervision, and lab-based training. Beyond teaching, he has led and collaborated on national research projects focused on phytochemical screening and antibiotic resistance. Dr. Azam has played active administrative roles, including BS program coordination and examination management. He is also a member of several Boards of Studies across universities in Khyber Pakhtunkhwa, contributing to academic planning and quality assurance. His career highlights a balance of academic instruction, impactful research, institutional service, and mentorship in the fields of microbiology, biotechnology, and infectious disease research.

Awards and Honors 

Dr. Sadiq Azam was awarded the prestigious HEC Indigenous Scholarship for his M.Phil to PhD studies, recognizing his academic excellence and potential in scientific research. This scholarship provided vital support for his doctoral work in biotechnology at the University of Peshawar and laid the foundation for a research career focused on combating antimicrobial resistance and exploring plant-based therapeutic alternatives. In addition to academic funding, Dr. Azam has successfully secured competitive research grants from Pakistan’s Higher Education Commission (HEC) and the Directorate of Science and Technology (DoST). These projects, as both Principal and Co-Principal Investigator, reflect national recognition of his expertise and contributions. His continued involvement in funded research projects underscores his credibility and leadership in the scientific community. His honors not only represent personal achievements but also contribute to the growth of biotechnology research capacity in Pakistan. He remains committed to advancing microbiological science through innovation and collaboration.

Research Focus 

Dr. Sadiq Azam’s research centers on bacteriological profiling, molecular genetics of antibiotic resistance, and the pharmacological evaluation of medicinal plants. His primary focus is the identification of resistance genes in clinical isolates, including extended-spectrum β-lactamase (ESBL) and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae. He employs molecular characterization techniques such as PCR, MIC testing, analytical profiling, and in-silico drug design to combat emerging bacterial threats. A parallel area of interest lies in the bioassay screening and phytochemical analysis of traditional medicinal plants like Silene conoidea, Sarcococca saligna, and Pinus wallichiana, aiming to discover novel antimicrobial compounds. His integrated approach bridges clinical microbiology with natural product chemistry, addressing global challenges in antibiotic resistance and infectious disease management. Through research supervision and project leadership, he actively contributes to building Pakistan’s research capacity in biotechnology, while aligning with global health priorities on antimicrobial stewardship and sustainable therapeutics.

Publication Top Notes

Title: Design and Validation of a Polyunit Epitope Vaccine Against Enterococcus faecium
Journal: Journal of Computational Biophysics and Chemistry
Summary:
This study likely focuses on the computational design and validation of a multi-epitope subunit vaccine targeting E. faecium, a notorious multidrug-resistant pathogen. The vaccine design may have used immunoinformatics tools to identify epitopes and predict immunogenicity.

Title: Towards Precision Epitopes Based Vaccine Against Enterococcus faecalis by Integrating Vaccinomics, Reverse Vaccinology and Biophysics Approaches
Journal: Biochemistry and Biophysics Reports
Summary:
The paper integrates vaccinomics and reverse vaccinology to identify precision epitopes for a vaccine targeting E. faecalis. It likely combines computational prediction, immunological profiling, and structural biophysics to develop a targeted vaccine strategy.

Title: Current Pattern of Antibiotic Resistance and Molecular Characterization of Virulence Genes in Klebsiella pneumoniae Obtained from Urinary Tract Infection (UTIs) Patients, Peshawar
Journal: PLOS ONE
Summary:
This research investigates antibiotic resistance patterns and the genetic basis of virulence in K. pneumoniae strains isolated from UTI patients in Peshawar. Likely includes PCR-based detection of virulence genes and antibiotic susceptibility profiling.

Title: Elucidating the Resistance Mechanisms and Binding Pattern of Novel Oxa-48-like Carbapenemases Covalent Inhibitors: A Hybrid Experimental and In Silico Approach
Journal: Journal of Molecular Structure
Summary:
The article explores how novel covalent inhibitors interact with Oxa-48-like carbapenemases—enzymes that confer resistance to carbapenem antibiotics. Uses both computational modeling and experimental data to understand resistance and inhibitor design.

Title: Green Synthesis and Characterisation of Desmodium podocarpum-Mediated Silver Nanoparticles and Their Biological Activities
Journal: Natural Product Research
Summary:
Focuses on the eco-friendly synthesis of silver nanoparticles using Desmodium podocarpum plant extract. Likely includes characterization (UV-Vis, SEM, FTIR) and evaluation of antimicrobial or antioxidant properties.

Conclusion 

Dr. Sadiq Azam stands as a leading academic and researcher in Pakistan’s biotechnology and microbiology landscape. His multidisciplinary expertise combines molecular microbiology, antimicrobial resistance research, and natural product pharmacology. With a strong academic foundation and over a decade of professional experience, he has contributed significantly to both science and education through impactful research, project leadership, and student mentorship. His work aligns with urgent global health issues such as drug-resistant infections and the search for alternative therapies. He has successfully led nationally funded projects and fostered collaborations across institutions. As an educator, Dr. Azam is deeply engaged in curriculum design, teaching innovation, and research supervision, shaping the next generation of scientists. His fluency in English, Urdu, and Pashto enables effective communication and outreach across diverse academic and community settings. Dr. Azam exemplifies the role of a dedicated researcher and educator committed to scientific advancement, public health improvement, and academic excellence in Pakistan.

Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award

Mr. Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award 

Research Scholar at University of Madras, India

Ragala Venkata Nandha is a passionate young researcher currently pursuing his PhD in Medical Microbiology at Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Chennai. With a strong foundation in microbiological sciences, his work centers on antimicrobial resistance and advanced diagnostic techniques. He holds a Master’s degree in Medical Microbiology and a Bachelor’s in Medical Laboratory Technology. Nandha has contributed to multiple research projects funded by CMRG and RUSA 2.0, addressing clinical microbiology and drug resistance mechanisms. His scientific publications and conference presentations underscore his active engagement in cutting-edge research. As a first and co-author, he has contributed to reputed international journals and book chapters. He is a contributing member of the American Society for Microbiology and actively participates in conferences and workshops. Known for his practical expertise in molecular biology and microbial diagnostics, Nandha is committed to advancing solutions for combating infectious diseases and public health threats.

Professional Profiles

Scopus

Education

Ragala Venkata Nandha is academically trained in the field of microbiology and medical laboratory technology. He is currently enrolled in a PhD program in Medical Microbiology at the Department of Microbiology, Dr. ALM PG IBMS, University of Madras, where he is investigating antimicrobial resistance mechanisms. Prior to his doctoral studies, he earned his Master of Science (M.Sc.) in Medical Microbiology from the same institute, where he conducted research on probiotic enhancement. His undergraduate studies were in Medical Laboratory Technology (B.Sc. MLT) at Dr. NTR University, Vijayawada, Andhra Pradesh. Throughout his academic journey, Nandha has consistently focused on clinical microbiology, diagnostics, and molecular biology. His education has provided him with solid theoretical grounding and extensive hands-on laboratory experience in handling clinical specimens, performing molecular diagnostics, and applying modern research methodologies to real-world medical problems. His academic foundation supports his current research in combating multidrug-resistant pathogens.

Experience

Ragala Venkata Nandha has gained practical and research experience through his roles as a Project Fellow in two major funded research projects. He is currently working as a CMRG Project Fellow in the Department of Genetics at Dr. ALM PG IBMS, University of Madras, where he is developing a multiplex LAMP assay for rapid detection of resistance genes in colistin-resistant Enterobacteriaceae. Prior to this, he served as a RUSA 2.0 Project Fellow, focusing on the neuroimmunoendocrine effects of natural resources in neurodegenerative diseases. His experience includes microbial culture, molecular techniques such as PCR and sequencing, antimicrobial susceptibility testing, and analysis of co-resistance patterns. He also has hands-on training in animal handling and diagnostic laboratory workflows. These roles have enhanced his understanding of translational research and enabled him to contribute significantly to microbiology and infectious disease research at the institutional and national levels.

Research Focus 

Ragala Venkata Nandha’s research is centered on antimicrobial resistance (AMR) and molecular diagnostics. His current PhD project involves the isolation and molecular profiling of carbapenem- and colistin-resistant Gram-negative bacteria from clinical samples. The research aims to understand co-resistance patterns and the evolutionary mechanisms underlying these pathogens. In the CMRG project, he is developing a multiplex LAMP assay to detect mcr-1 to mcr-9 genes responsible for colistin resistance. His postgraduate work explored the prebiotic potential of spinach on probiotic growth, contributing to the understanding of gut microbiota modulation. He has also studied nanotechnology-based antimicrobial agents like eco-friendly silver nanoparticles. His work integrates microbiology, molecular biology, and bioinformatics to address critical healthcare challenges. With expertise in techniques like real-time PCR, Sanger sequencing, and bioinformatics analysis, his goal is to innovate diagnostics and therapeutic strategies for combating drug-resistant infections and improving clinical outcomes.

Publication Top Notes

Title: Advancing beyond conventional vaccines: The potential of next-generation vaccines in combatting antibiotic-resistant bacteria

Journal: Indian Journal of Medical Microbiology

Summary

This article explores the emerging landscape of next-generation vaccines designed to address the growing threat of antibiotic-resistant bacteria. Unlike traditional vaccines, which primarily rely on attenuated or inactivated pathogens, next-gen vaccines leverage novel platforms such as mRNA, recombinant proteins, vector-based systems, and nanoparticle technologies. The paper highlights how these vaccines offer greater specificity, faster development timelines, and adaptability against evolving bacterial strains. It also examines clinical trials, current research trends, and regulatory challenges, emphasizing the crucial role these vaccines play in reducing reliance on antibiotics and slowing antimicrobial resistance (AMR) worldwide.

Conclusion

Ragala Venkata Nandha represents a new generation of focused, skilled, and research-driven microbiologists working at the intersection of clinical diagnostics and antimicrobial resistance. His academic foundation, complemented by ongoing doctoral research, showcases a strong commitment to scientific inquiry and innovation. From molecular biology and nanotechnology to clinical microbiology and bioinformatics, his multidisciplinary approach addresses urgent public health concerns. His contributions as a project fellow, author, and conference presenter reflect both technical expertise and scientific maturity. As a member of international scientific communities and contributor to peer-reviewed literature, he continues to build a credible research profile. With promising achievements in diagnostics development and microbial resistance studies, Nandha is well-positioned to make a lasting impact in translational microbiological research. His journey reflects a dedication not only to academic excellence but also to solving real-world health challenges through research, collaboration, and innovation. He is a valuable asset to the scientific and medical research community.